229 related articles for article (PubMed ID: 32060984)
21. Evaluation of a single subcutaneous infusion of carboplatin as adjuvant chemotherapy for dogs with osteosarcoma: 17 cases (2006-2010).
Simcock JO; Withers SS; Prpich CY; Kuntz CA; Rutland BE
J Am Vet Med Assoc; 2012 Sep; 241(5):608-14. PubMed ID: 22916858
[TBL] [Abstract][Full Text] [Related]
22. The tyrosine kinase inhibitor sorafenib decreases cell number and induces apoptosis in a canine osteosarcoma cell line.
Wolfesberger B; Tonar Z; Gerner W; Skalicky M; Heiduschka G; Egerbacher M; Thalhammer JG; Walter I
Res Vet Sci; 2010 Feb; 88(1):94-100. PubMed ID: 19665156
[TBL] [Abstract][Full Text] [Related]
23. Melarsomine suppresses canine osteosarcoma cell survival via inhibition of Hedgehog-GLI signaling.
Nam A; Kim T; Li Q; Rebhun RB; Youn HY; Seo KW
J Vet Med Sci; 2019 Dec; 81(12):1722-1729. PubMed ID: 31645504
[TBL] [Abstract][Full Text] [Related]
24. Hemorrhagic cystitis in a dog receiving carboplatin.
MacDonald V; Dickinson R
J Am Anim Hosp Assoc; 2014; 50(1):67-70. PubMed ID: 24216493
[TBL] [Abstract][Full Text] [Related]
25. Comparison of carboplatin and doxorubicin-based chemotherapy protocols in 470 dogs after amputation for treatment of appendicular osteosarcoma.
Selmic LE; Burton JH; Thamm DH; Withrow SJ; Lana SE
J Vet Intern Med; 2014; 28(2):554-63. PubMed ID: 24512451
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of metronomic cyclophosphamide chemotherapy as maintenance treatment for dogs with appendicular osteosarcoma following limb amputation and carboplatin chemotherapy.
Matsuyama A; Schott CR; Wood GA; Richardson D; Woods JP; Mutsaers AJ
J Am Vet Med Assoc; 2018 Jun; 252(11):1377-1383. PubMed ID: 29772973
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Weight Change During Carboplatin Therapy in Dogs With Appendicular Osteosarcoma.
Story AL; Boston SE; Kilkenny JJ; Singh A; Woods JP; Culp WTN; Skorupski KA; Lu X
J Vet Intern Med; 2017 Jul; 31(4):1159-1162. PubMed ID: 28503759
[TBL] [Abstract][Full Text] [Related]
28. Effects of etoposide alone and in combination with piroxicam on canine osteosarcoma cell lines.
Ong SM; Saeki K; Tanaka Y; Nishimura R; Nakagawa T
Vet J; 2016 Dec; 218():51-59. PubMed ID: 27938709
[TBL] [Abstract][Full Text] [Related]
29. Use of single-agent carboplatin as adjuvant or neoadjuvant therapy in conjunction with amputation for appendicular osteosarcoma in dogs.
Phillips B; Powers BE; Dernell WS; Straw RC; Khanna C; Hogge GS; Vail DM
J Am Anim Hosp Assoc; 2009; 45(1):33-8. PubMed ID: 19122062
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of circulating microRNA-214 and -126 in dogs with appendicular osteosarcoma receiving amputation and chemotherapy.
Heishima K; Meuten T; Yoshida K; Mori T; Thamm DH
BMC Vet Res; 2019 Jan; 15(1):39. PubMed ID: 30683101
[TBL] [Abstract][Full Text] [Related]
31. Biological activity of dihydroartemisinin in canine osteosarcoma cell lines.
Hosoya K; Murahari S; Laio A; London CA; Couto CG; Kisseberth WC
Am J Vet Res; 2008 Apr; 69(4):519-26. PubMed ID: 18380584
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic study and evaluation of the safety of taurolidine for dogs with osteosarcoma.
Marley K; Helfand SC; Simpson J; Mata JE; Tracewell WG; Brownlee L; Bracha S; Séguin B
J Exp Clin Cancer Res; 2013 Oct; 32(1):74. PubMed ID: 24422857
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxic action of Brazilian propolis in vitro on canine osteosarcoma cells.
Cinegaglia NC; Bersano PR; Búfalo MC; Sforcin JM
Phytother Res; 2013 Sep; 27(9):1277-81. PubMed ID: 23074147
[TBL] [Abstract][Full Text] [Related]
34. Update on the biology and management of canine osteosarcoma.
Chun R; de Lorimier LP
Vet Clin North Am Small Anim Pract; 2003 May; 33(3):491-516, vi. PubMed ID: 12852233
[TBL] [Abstract][Full Text] [Related]
35. Current veterinary therapy in canine osteosarcoma.
Kirpensteijn J
Vet Q; 1994 Apr; 16 Suppl 1():24S-25S. PubMed ID: 7801461
[No Abstract] [Full Text] [Related]
36. Toxicity and efficacy of cisplatin and doxorubicin combination chemotherapy for the treatment of canine osteosarcoma.
Chun R; Garrett LD; Henry C; Wall M; Smith A; Azene NM
J Am Anim Hosp Assoc; 2005; 41(6):382-7. PubMed ID: 16267062
[TBL] [Abstract][Full Text] [Related]
37. Expression of the hedgehog signalling pathway and the effect of inhibition at the level of smoothened in canine osteosarcoma cell lines.
Nam A; Song WJ; An JH; Rebhun RB; Youn HY; Seo KW
Vet Comp Oncol; 2022 Dec; 20(4):778-787. PubMed ID: 35521940
[TBL] [Abstract][Full Text] [Related]
38. Effect of zoledronic acid and amputation on bone invasion and lung metastasis of canine osteosarcoma in nude mice.
Wolfe TD; Pillai SP; Hildreth BE; Lanigan LG; Martin CK; Werbeck JL; Rosol TJ
Clin Exp Metastasis; 2011 Apr; 28(4):377-89. PubMed ID: 21374084
[TBL] [Abstract][Full Text] [Related]
39. Which dogs with appendicular osteosarcoma benefit most from chemotherapy after surgery? Results from an individual patient data meta-analysis.
Schmidt AF; Groenwold RH; Amsellem P; Bacon N; Klungel OH; Hoes AW; de Boer A; Kow K; Maritato K; Kirpensteijn J; Nielen M
Prev Vet Med; 2016 Mar; 125():116-25. PubMed ID: 26796424
[TBL] [Abstract][Full Text] [Related]
40. HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.
Dailey DD; Anfinsen KP; Pfaff LE; Ehrhart EJ; Charles JB; Bønsdorff TB; Thamm DH; Powers BE; Jonasdottir TJ; Duval DL
BMC Vet Res; 2013 Jul; 9():130. PubMed ID: 23816051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
